BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16079222)

  • 21. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
    Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
    J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
    Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
    Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fibre additions to flatbread flour mixes on glucose kinetics: a randomised controlled trial.
    Boers HM; van Dijk TH; Hiemstra H; Hoogenraad AR; Mela DJ; Peters HPF; Vonk RJ; Priebe MG
    Br J Nutr; 2017 Nov; 118(10):777-787. PubMed ID: 29110741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of duodenal glucose load on blood pressure in type 2 diabetes.
    Marathe CS; Horowitz M; Trahair LG; Bound M; Checklin H; Lange K; Rayner CK; Jones KL
    Diabetes Res Clin Pract; 2016 Mar; 113():38-40. PubMed ID: 26972959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
    Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia.
    Ahrén B; Holst JJ
    Diabetes; 2001 May; 50(5):1030-8. PubMed ID: 11334405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapy.
    Groop PH; Groop L; Tötterman KJ; Fyhrquist F
    Scand J Clin Lab Invest; 1986 Oct; 46(6):505-10. PubMed ID: 3535000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
    Ranganath LR; Beety JM; Morgan LM
    Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of glucose and xylose on blood pressure, gastric emptying and incretin hormones in healthy older subjects.
    Vanis L; Hausken T; Gentilcore D; Rigda RS; Rayner CK; Feinle-Bisset C; Horowitz M; Jones KL
    Br J Nutr; 2011 Jun; 105(11):1644-51. PubMed ID: 21294929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of partially depolymerized guar gum on acute metabolic variables in patients with non-insulin-dependent diabetes.
    Gatenby SJ; Ellis PR; Morgan LM; Judd PA
    Diabet Med; 1996 Apr; 13(4):358-64. PubMed ID: 9162612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
    O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL
    Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects.
    Trahair LG; Marathe CS; Standfield S; Rayner CK; Feinle-Bisset C; Horowitz M; Jones KL
    Int J Obes (Lond); 2017 Feb; 41(2):225-232. PubMed ID: 27840416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of gastric distension on blood pressure and superior mesenteric artery blood flow responses to intraduodenal glucose in healthy older subjects.
    Vanis L; Gentilcore D; Hausken T; Pilichiewicz AN; Lange K; Rayner CK; Feinle-Bisset C; Meyer JH; Horowitz M; Jones KL
    Am J Physiol Regul Integr Comp Physiol; 2010 Sep; 299(3):R960-7. PubMed ID: 20554933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed.
    Little TJ; Doran S; Meyer JH; Smout AJ; O'Donovan DG; Wu KL; Jones KL; Wishart J; Rayner CK; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E647-55. PubMed ID: 16684852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery.
    Kuo P; Chaikomin R; Pilichiewicz A; O'Donovan D; Wishart JM; Meyer JH; Jones KL; Feinle-Bisset C; Horowitz M; Rayner CK
    Regul Pept; 2008 Feb; 146(1-3):1-3. PubMed ID: 17964673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intraduodenal glucose concentration on blood pressure and heart rate in healthy older subjects.
    Gentilcore D; Doran S; Meyer JH; Horowitz M; Jones KL
    Dig Dis Sci; 2006 Apr; 51(4):652-6. PubMed ID: 16614984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
    Thazhath SS; Marathe CS; Wu T; Chang J; Khoo J; Kuo P; Checklin HL; Bound MJ; Rigda RS; Horowitz M; Jones KL; Rayner CK
    Diab Vasc Dis Res; 2017 Jan; 14(1):59-63. PubMed ID: 27941058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.